Presentations
-
July 16, 2017
Landscape analysis of biometric monitoring devices (BMDs) utilized in assessing cognition, sleep and mobility in Alzheimer’s disease and other age-related neurological diseases
Kern, V.D., et al.; “Landscape analysis of biometric monitoring devices (BMDs) utilized in assessing cognition, sleep and mobility in Alzheimer’s disease and other age-related neurological diseases.” Alzheimer’s Association International Conference, London, UK, July 16-20, 2017, Alzheimer’s & Dementia 12(7): Suppl., 1322. -
July 16, 2017
The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarker for enrichment in clinical trials for pre-dementia stages of Alzheimer’s disease
Conrado, D.J., et al.; “The Coalition Against Major Diseases: Towards U.S. FDA qualification of hippocampal volume as a biomarker for enrichment in clinical trials for pre-dementia stages of Alzheimer’s disease.” Alzheimer’s Association International Conference, London, UK, July 16-20, 2017, Alzheimer’s & Dementia 12(7): Suppl., 1259. - June 30, 2017
- June 27, 2017
- June 9, 2017
